Assessment of Reinjection Numbers and Intervals for Diabetic Macular Edema Patients Who Received Dexamethasone Intravitreal Implants in Germany and Switzerland
Albert J Augustin,1 Matthias D Becker,2,3 Katja Hatz,4 Hakan Kaymak,5 Andrew Shirlaw6 1Eye Care Clinic, Karlsruhe, Germany; 2Department of Ophthalmology, Zurich City Hospital, Zurich, Switzerland; 3Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany; 4Vista Klinik Binningen, S...
Saved in:
Main Authors: | Augustin AJ, Becker MD, Hatz K, Kaymak H, Shirlaw A |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c4a4f13f06b748afa25c5f624f49d2cd |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
by: Thomas BJ, et al.
Published: (2016) -
Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema
by: Rodolfo Mastropasqua, et al.
Published: (2018) -
Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN®) and Follow-Up Considerations/Recommendations
by: Adán A, et al.
Published: (2020) -
Real-World Outcomes in Diabetic Macular Edema for the 0.2 μg/Day Fluocinolone Acetonide Implant: Case Series from the Midlands, UK
by: Mushtaq B, et al.
Published: (2021) -
Update on corticosteroids for diabetic macular edema
by: Schwartz SG, et al.
Published: (2016)